All the Therapeutic System Drugs
Herbal Medicinal Product. Agni Casti Fructus Dry Extract (7-11:1) 4 mg, Ethanol 70% v/v. F.C TABS: 30. 1 film-coated tablet once dly. See lit.
Premenstrual synd., mastodynia.
C/I: Hypersens.
Progestogen. Dydrogesterone 10 mg. FC Tabs: 42.
Dosage: see lit.
Cases where progest. suppl. is needed.
C/I: Hypersens. Vag. bleeding, where the cause has not been establ. Tmt. for luteal supp. as part of an Assisted Reproductive Technology (ART) tmt. should be discont. upon diagn. of abortion or miscarr. Pres. of sev. liver disord., or sev. liver disord. in med. hist. until liver funct. values have returned to normal. C/I for use of oestrogens in combin. with progestogens such as dydrogesterone in comb. ther. Known or susp. sex horm. dep. malign.
Progestogen. Norethisterone Acetate 5 mg. TABS: 20. See lit.
Dysfunct. bleed., primary and second.
amenorrh., premenstrual syndr.,
mastopathy, uterine hypoplasia, timing of
menstruation, endometriosis.
C/I: Pregn., severe disturb. liver funct.,
Dubin-Johnson syndr., Rotor syndr.,
past, present liver tumors, history
jaundice, severe prurit., herpes during
pregn., thromboembol. processes
Estrogen, Progestogen. Estradiol Valerate 2 mg, Norgestrel 0.5 mg. TABS: 21, 28. 1 white tab. dly. for 11 days,
then 1 brown tab. dly for 10 days.
Thereaft. 7 tab.-free days. See lit.
Two phase prep. for climacteric, cycle
disturbances.
Progestogen. Medroxyprogesterone Acetate 5 mg. TABS.: 100, 24. Endometriosis: Oral MPA 10 mg three times per day for 90 consec. days, begin. on the 1ST d of the menstrual cycle.
Menopaus. Vasomotor Sympt.: Oral MPA 10-20 mg/d given continuous.
Diagn. of prim. and secon. Amenorrhea: Oral MPA 2.5-10 mg/d for 5-10 d.
Tmt. of second. Amenorrhea: Oral MPA 2.5- 10 mg dly. for 5-10 days, for 3 consecut. cycles. In pts. with hypotrophy of the endometrium, estrogens should be used concomit. with MPA ther.
Dysfunctional (Anovulatory) Uterine Bleed.: Oral MPA 2.5 to 10 mg/ d for 5–10 d for 2-3 cycles and then discont. to see if the dysfunct. has regressed. If bleed. occurs from a poorly proliferative endometrium, estrogens should be used concomit. with MPA ther.
Opposition of endometrial effects of estrogen in menopaus. women being treated with estrogen (Hormone Therapy [HT]): For women taking 0.625 mg of conjugated estrogen or an equivalent dly. dose of another estrogen, MPA can be given in one of two regimens:
Continuous regimen of MPA- Oral MPA 2.5 to 5.0 mg dly.
Sequent. regimen of MPA- Oral MPA 5 to 10 mg dly. for 10- 14 consecut. d. of a 28-d or monthly cycle.
Indicated for cases requiring progesterone supplem.
C/I: Hypersens. Known/suspect. preg. Known, past or suspect. breast cancer; Previous idiopathic or current venous thromboembolism (DVT, PE). Active/recent arterial thromboembolic dis. (e.g angina, MI); Acute liver dis., or a history of liver dis. as long as liver funct. tests have failed to return to normal. Porphyria.
Estrogen, Progestogen. Drospirenone 3 mg, Ethynilestradiol 0.02 mg. F.C. TABS: 1 x 28, 3 x 28. 1 tab dly at
same time ea. day for 28 consec. days.
Ea. subseq. pack to be started day aft.
last tab of prev. pack. See lit.
Oral contracept., mod. acne vulgar.,
premens. dysphor. disord. (PMDD).
